Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Supportive Care
Based on the FDA indication is fezolinetant (Veozah) in menopause induced hot flashes, is it also used for Aromatase Inhibitor induced hot flashes in the clinical setting?
And where are you offering it in the order of supportive care measures?
Related Questions
What, if any, resources exist with recommendations regarding the timing and toxicity of radiation in patients who have received or are currently on immunotherapy?
Can defibrotide be given safely for VOD in patients with refractory thrombocytopenia to platelet transfusions?
In SIADH due to malignancy, do you prefer to use free water restriction or salt tablets?
What are your top takeaways in Hematologic Malignancies from ASH 2024?
Do you regularly incorporate oral cryotherapy in your practice for patients receiving oxaliplatin to decrease the risk of thermal hyperalgesia?
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
How would you manage a patient with FIGO stage IIIB endometrial carcinoma who developed significant back pain with Carboplatin/Paclitaxel cycle 1, which worsened during cycle 2?
In patients with cholangiocarcinoma who qualify for HAIP therapy, would you recommend treating with chemotherapy and immunotherapy?
Would you consider neoadjuvant immunotherapy in a patient with Lynch syndrome and urothelial cancer?
How do you manage anemia associated with belzutifan therapy?